Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Rice

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretionM J Bray, T M Vick, N Shah, et al.
Gynecologic Oncology|December 1, 1995
Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 casesD T Kato, J A Ferry, A Goodman, et al.
Gynecologic Oncology|March 1, 1996
Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III diseaseB A Goff, R Sainz de la Cuesta, H G Muntz, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretionM J Bray, T M Vick, N Shah, et al.
Gynecologic Oncology|December 1, 1995
Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 casesD T Kato, J A Ferry, A Goodman, et al.
Gynecologic Oncology|March 1, 1996
Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III diseaseB A Goff, R Sainz de la Cuesta, H G Muntz, et al.
Pageof 5